December 7, 2009 — The US Food and Drug Administration (FDA) has approved a new indication for quetiapine fumarate extended-release tablets (Seroquel XR, AstraZeneca Pharmaceuticals, LP), allowing ...

LONDON, Nov. 13, 2008-AstraZeneca today announced that the once-daily formulation SEROQUEL XR (quetiapine fumarate extended release tablets) and SEROQUEL (quetiapine fumarate) have been approved under ...

The XR in SEROQUEL XR stands for extended release. This means that medication is released around the clock. SEROQUEL XR is taken once daily as prescribed by your health care professional. SEROQUEL XR ...

WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca (NYSE: AZN) today announced it has entered into a settlement agreement in its U.S. SEROQUEL XR® patent infringement litigation against Handa ...

NEW YORK CITY -- Patients with borderline personality disorder showed significant improvements when treated with long-acting antipsychotic agent quetiapine fumarate (Seroquel XR) in a ...

Intellipharmaceutics International earned tentative approval from the Food and Drug Administration for its quetiapine fumarate tablets. The drug, intended to treat schizophrenia and bipolar disorder, ...

Launched in 1997, SEROQUEL (R) (quetiapine fumarate tablets) has been prescribed to millions of patients worldwide. It is approved in 88 countries for the treatment of schizophrenia, in 79 countries ...

AstraZeneca today filed a lawsuit against the US Food and Drug Administration (FDA) in the US District Court for the District of Columbia to overturn the FDA's denial on 7 March 2012 of Citizen ...

WILMINGTON, Del. The Food and Drug Administration has approved once-daily Seroquel XR (quetiapine fumarate) Extended-Release Tablets for maintenance treatment of schizophrenia in adult patients, ...

Russia is facing a shortage of drugs which are used for the treatment of schizophrenia, psychosis, bipolar disorder, and ...

On September 20, the European Commission approved 30- and 45-mg strengths of oseltamivir phosphate capsules (Tamiflu, Hoffmann-La Roche Ltd) for the treatment and prevention of influenza types A and B ...